Since the epidemic began in 1981, more than 700,000 people have died from AIDS-related causes in the United States. That number continues to grow, though at a dramatically slower pace than the crisis years of the late 1980s and early 1990s. In the most recent year of national data, 4,589 people in the U.S. died with HIV listed as the underlying cause, a rate of 1.3 deaths per 100,000 people.
The Peak Years and the Treatment Turning Point
AIDS-related deaths in the U.S. climbed steeply through the 1980s and peaked around 1995, when roughly 50,000 Americans were dying each year. At that point, AIDS was the leading cause of death for all Americans aged 25 to 44. The introduction of combination antiretroviral therapy in 1996 changed the trajectory almost overnight. Within a few years, mortality dropped by approximately 50% compared to people who had no access to those treatments.
The decline has continued in the decades since. Deaths fell from tens of thousands per year in the mid-1990s to under 5,000 in the most recent CDC mortality data. That shift reflects both more effective medications and earlier diagnosis, which allows treatment to begin before the immune system is severely damaged.
What People With HIV Die From Today
The cause-of-death profile for people living with HIV has shifted substantially. In the late 1990s, AIDS-defining illnesses (severe infections and cancers that strike when the immune system collapses) accounted for about 49% of deaths among people on treatment. By 2016 to 2020, that figure had dropped to 16%.
Meanwhile, non-AIDS cancers rose from 5% of deaths to 19% over the same period, and cardiovascular disease accounted for about 8% of classified deaths. In other words, as antiretroviral therapy keeps the virus suppressed, people with HIV are increasingly dying from the same conditions that affect the general population: heart disease, lung cancer, liver disease. AIDS itself, while still the single largest category at 25% of all classified deaths in one large study spanning 1996 to 2020, is no longer the overwhelming driver it once was.
Who Is Most Affected
The burden of HIV-related death falls unevenly across racial and ethnic groups. In 2023, Black Americans had an HIV-related death rate of 18.1 per 100,000, more than three times the national rate of 5.6 per 100,000. Black Americans also represented nearly 40% of all people classified with advanced AIDS, despite making up about 13% of the U.S. population. These disparities reflect longstanding gaps in access to healthcare, insurance coverage, housing stability, and the stigma that can delay testing and treatment.
Where Deaths Are Concentrated
Geography plays a significant role. The U.S. South consistently has the highest HIV-related death rates, driven by a combination of higher infection rates, fewer healthcare resources in rural areas, and state-level differences in Medicaid expansion. In 2023, the places with the highest HIV-related death rates per 100,000 among people with diagnosed HIV were the District of Columbia (8.9), Georgia (3.1), Florida (2.9), Delaware (2.8), and Louisiana (2.8). The national average was 1.6 per 100,000 among people aged 13 and older living with diagnosed HIV.
These five areas alone account for a disproportionate share of the national toll, and they overlap heavily with the regions targeted by the federal “Ending the HIV Epidemic” initiative launched in 2019.
Putting the Numbers in Context
A cumulative toll of more than 700,000 deaths makes AIDS one of the deadliest epidemics in American history, comparable in scale to U.S. combat deaths across all 20th-century wars combined. The difference today is pace. At the epidemic’s worst, someone diagnosed with AIDS had a life expectancy measured in months. Now, a 20-year-old who starts treatment early and stays on it can expect to live into their 70s or beyond.
Still, nearly 4,600 deaths a year is not zero. Most of those deaths are preventable with existing tools: testing, treatment that suppresses the virus to undetectable levels, and pre-exposure prophylaxis for people at high risk. The gap between what medicine can do and what actually reaches people, particularly in the South and among Black and Latino communities, is where most of the remaining mortality sits.